Heyholder
‹ Activism FilingsMajor

KUMHO Engineering & Construction Co., Ltd. Songdo Severance Hospital construction contract won, KRW 372.0 billion

KUMHO Engineering & Construction Co., Ltd.· Single Sales/Supply Contract

AI summary · Not investment advice

The company signed a KRW 372.0 billion contract with Yonsei University Health System to build Songdo Severance Hospital, 18.43% of its annual sales.

Contract amount

KRW 372.0 billion

Key facts

Counterparty
Yonsei University Health System
Contract details
Songdo Severance Hospital new construction workConstruction order
% of revenue
18.43%
Contract period
Nov 12, 2026 – Dec 31, 2028
Recent revenue
KRW 2.0 trillionBased on consolidated financial statements as of end of 2025
Supply region
162-1 Songdo-dong, Yeonsu-gu, Incheon
Payment terms
Billed and paid according to construction progressNo down payment or advance payment
Contract date
Nov 12, 2026

Commentary

AI commentary · Not investment advice

What happened

Kumho Engineering & Construction signed a contract with Yonsei University Health System to build the Songdo Severance Hospital. The contract is worth KRW 372.0 billion. The site is at 162-1 Songdo-dong, Yeonsu-gu, Incheon.

In the company's terms

The amount equals 18.43% of the company's revenue for the past year, which was KRW 2,018.5 billion on a consolidated basis at the end of 2025.

What changes for shareholders

The contract period runs from Nov 12, 2026 to Dec 31, 2028. There is no down payment or advance payment. The company bills and gets paid as the work progresses.

Earlier Single Sales/Supply Contract filings from this company

Last 2 years · Contract amount · KRW 100M
  1. KRW 376.6 billion
  2. KRW 327.9 billion
  3. KRW 202.5 billion

■ This disclosure

Filings of the same type
FiledCounterpartyContract amount% of revenue
26.11.11Rural Development Administration, National Institute of Animal Science, Livestock Resources Development DepartmentKRW 327.9 billion16.25%
26.08.04Korea Western Power Co., Ltd.KRW 376.6 billion18.23%

Comments

No comments yet

Comments from shareholders will appear here.